Enrollment Completed for Phase 3 REFALS Trial Evaluating Levosimendan in ALS Patients
The Phase 3 REFALS trial exploring the impact of oral levosimendan (ODM-109) in patients with amyotrophic lateral sclerosis (ALS)…
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
The Phase 3 REFALS trial exploring the impact of oral levosimendan (ODM-109) in patients with amyotrophic lateral sclerosis (ALS)…
Multidisciplinary care with timely use of respiratory and feeding support contributes to increased survival for people with amyotrophic lateral…
Vitamin D supplementation can help overcome low levels of the vitamin often detected in people with amyotrophic lateral sclerosis (ALS).
MediciNova has launched the Phase 2b/3 clinical trial that will explore the potential of ibudilast (MN-166) in…
A diet monitoring app can help amyotrophic lateral sclerosis (ALS) patients to manage their calorie intake in order to maintain…
The U.S. Food and Drug Administration approved MediciNova’s plans for a pivotal Phase 2b/3 clinical trial that will explore…
Increasing blood flow in the spinal cord by injecting a long-acting vasodilator can help prevent the progression of amyotrophic lateral…
Widely used to study several human diseases, zebrafish can now be a useful preclinical model to study amyotrophic lateral sclerosis…
Stem cell therapy using a certain type of stem cell called human mesenchymal stromal cells (hMSCs) may have the potential…
New genetic mutations in the coding sequence of the GLT8D1 enzyme have been identified and linked to inherited amyotrophic…